Your browser doesn't support javascript.
loading
IL-33 improves the suppressive potential of regulatory T cells in patients with type 1 diabetes.
Ryba-Stanislawowska, Monika; Buksa, Laura; Brandt, Agnieszka; Juhas, Ulana; Mysliwiec, Malgorzata.
Afiliação
  • Ryba-Stanislawowska M; Department of Immunology, Medical University of Gdansk, Poland. Electronic address: akinomab@gumed.edu.pl.
  • Buksa L; Department of Immunology, Medical University of Gdansk, Poland.
  • Brandt A; Clinic of Pediatrics, Department of Diabetology and Endocrinology, Medical University of Gdansk, Poland.
  • Juhas U; Department of Immunology, Medical University of Gdansk, Poland.
  • Mysliwiec M; Clinic of Pediatrics, Department of Diabetology and Endocrinology, Medical University of Gdansk, Poland.
Diabetes Res Clin Pract ; 128: 67-73, 2017 Jun.
Article em En | MEDLINE | ID: mdl-28448894
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfócitos T Reguladores / Diabetes Mellitus Tipo 1 / Interleucina-33 Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfócitos T Reguladores / Diabetes Mellitus Tipo 1 / Interleucina-33 Idioma: En Ano de publicação: 2017 Tipo de documento: Article